Dotatate ( DrugBank: Dotatate )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
84	Sarcoidosis	4

84. Sarcoidosis

---

Clinical trials : 149 /  Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03746847 (ClinicalTrials.gov)	December 1, 2018	29/10/2018	PET Imaging in Patients With Suspected Cardiac Sarcoidosis	Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis	Cardiac Sarcoidosis	Drug: Gallium-68 DOTATATE	University of Pennsylvania	Advanced Accelerator Applications	Completed	18 Years	N/A	All	20		United States
2	NCT03549598 (ClinicalTrials.gov)	July 20, 2018	25/5/2018	d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	Cardiac Sarcoidosis	Drug: 68Ga-DOTATATE PET/CT;Drug: 18FDG PET/CT scan;Drug: 13NH3 PET/CT scan	Mayo Clinic	NULL	Completed	18 Years	N/A	All	15	Phase 4	United States
3	NCT02812849 (ClinicalTrials.gov)	June 2016	22/6/2016	Somatostatin Receptor Imaging in Cardiac Sarcoidosis	Somatostatin Receptor Imaging in Cardiac Sarcoidosis	Cardiac Sarcoidosis	Drug: Cu-64 DOTATATE	Rigshospitalet, Denmark	NULL	Withdrawn	18 Years	N/A	All	0		Denmark
4	NCT02546388 (ClinicalTrials.gov)	October 2015	9/9/2015	Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis	Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis	Sarcoidosis	Drug: Indium-111 Pentreotide;Drug: Gallium-68 DOTATATE	Marcelo F. Di Carli, MD, FACC	Mallinckrodt	Completed	18 Years	90 Years	All	17	N/A	United States